Table 1.
10 μM GSNO |
0.1 mM GSNO |
0.5 mM GSNO |
||||
S-NO | S-SG | S-NO | S-SG | S-NO | S-SG | |
C172 | − | + | − | + | + | + |
C260 | + | + | + | + | + | + |
C266 | + | + | + | + | + | + |
C287 | − | − | − | − | + | + |
Purified recombinant TGA1 was treated with different concentrations of GSNO for 10 min. Residual GSNO was removed by gel filtration. After tryptic digestion, the Cys-containing peptides were analyzed for their modification by nano-liquid chromatography tandem mass spectrometry.